The Clorox Company
Every calculator, already run for CLX
Open the full toolkit →You have the numbers on CLX. Get the argument.
A written report on which of these readings actually decide the outcome for The Clorox Company, what has to stay true for the price to work, and the specific thing that would break it. The first one is free.
Key market data
Analyst consensus
19 analysts covering CLXAnalyst Price Target Disagreement for The Clorox Company
Wall Street's bull case implies +81% from the current price; the bear case implies -9%. A 91% spread signals high analyst disagreement — run your own DCF to anchor on fundamentals rather than street consensus.
Ownership & short interest
Insider Trading Activity for CLX
| Insider | Role | Type | Shares | Price | Value | Date | Filing |
|---|---|---|---|---|---|---|---|
About The Clorox Company
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The company home care cleaning and disinfecting products and laundry additives, skin sanitization and cleaning products, professional cleaning and disinfecting products, and professional food service products under the Clorox, Clorox2, Pine-Sol, Scentiva, Tilex, Liquid-Plumr, Formula 409, Purell, GOJO, CloroxPro, Clorox Healthcare, Hidden Valley, Poett, Clorinda, and Chux brands. It also provides bags and wraps, cat litter, and grilling products under the Glad, Fresh Step, Scoop Away, Kingsford, and Ever Cle…
CLX — frequently asked
Is CLX a buy right now?
Wall Street's consensus rating on The Clorox Company is Hold across 19 analysts, with a mean price target of $100.76 (+19% vs. the current $85.00). Ratings are a starting point — run the DCF and check the financial-health readings above before deciding.
Is CLX overvalued?
CLX trades at 17.7x trailing earnings, against a DCF fair value of $35 per share. The current price implies 17% annual free-cash-flow growth for a decade. Open the DCF or reverse-DCF tool to change the assumptions and see the range.
When is CLX's next earnings date?
The Clorox Company is next scheduled to report earnings around Nov 3, 2026. A full CLX research report from Basis Report covers the setup into that print — estimates, the beat/miss record, and what would move the thesis.
What is the analyst price target disagreement for The Clorox Company?
Analysts covering The Clorox Company (CLX) range from a bear-case target of $77.00 to a bull-case high of $154.00, with a mean consensus target of $100.76 across 17 analysts. The spread of $77.00 (91% of the current price) indicates high disagreement on the outlook. Run the DCF calculator to build your own estimate independent of street consensus.
Compare The Clorox Company against related stocks
Explore additional stock overview pages and jump directly into full report generation for each symbol.
Sector peers
Most-followed names in the same sector.
Nearby tickers
Additional public equities from our tracked universe.
Market leaders
Large-cap symbols investors frequently compare.
Investor Guides For The Clorox Company
Start with the evergreen guides that matter most for Consumer Defensive, then move back into the ticker page when you want to pressure-test the framework on a live name.
Generate your full CLX research report
DCF model, five-year financials, moat assessment, a BUY/HOLD/SELL rating, and the risks that matter — on The Clorox Company, in minutes. 3 free reports included with every account — no credit card required.